D
Bangkok Dusit Medical Services Public Company Limited BDULF
$0.56 $0.000.81% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Bangkok Dusit Medical Services Public Company Limited (BDMS), traded in the U.S. OTC market under the symbol BDULF, is one of the largest private healthcare operators in Southeast Asia and the largest private hospital network in Thailand by market capitalization and hospital scale. The company operates in the healthcare services industry, with core activities centered on hospital management, specialized medical treatment, diagnostics, rehabilitation, preventive healthcare, and wellness services. BDMS generates most of its revenue through inpatient and outpatient hospital services, with additional contributions from laboratory services, pharmaceuticals, and healthcare-related support businesses.

The company’s primary hospital brands include Bangkok Hospital, Samitivej Hospital, BNH Hospital, Phyathai Hospital, and Paolo Hospital, which collectively serve domestic patients, expatriates, and international medical tourists. BDMS has built a strong competitive position through its nationwide hospital network, physician base, specialist centers, and reputation in complex tertiary care. Founded through the merger and expansion of several Thai hospital groups beginning in the late 20th century, BDMS evolved from a domestic hospital operator into a regional healthcare platform with a strong focus on advanced medicine, digital health integration, and international patient services.

Business Operations

BDMS operates through multiple healthcare and hospital management businesses, with revenue primarily derived from patient care services across its hospital network. Its core operating structure includes hospital operations under major brands such as Bangkok Hospital Group, Samitivej Group, Phyathai Group, Paolo Group, and BNH Hospital. The company also operates specialized medical centers covering cardiology, oncology, orthopedics, fertility treatment, and neurological care. In addition to hospital services, BDMS maintains interests in laboratory operations, pharmaceutical distribution, rehabilitation, preventive medicine, and wellness programs.

The company’s operations are concentrated in Thailand but are internationally oriented due to its substantial medical tourism business, particularly serving patients from the Middle East, ASEAN countries, China, and other international markets. BDMS controls significant healthcare infrastructure assets, including hospital campuses, specialty centers, and digital health systems. The company has also developed partnerships with international medical institutions and maintains affiliations designed to support physician training, technology transfer, and advanced treatment standards. Its vertically integrated healthcare ecosystem supports recurring patient demand and broad service coverage across multiple income segments.

Strategic Position & Investments

BDMS has positioned itself as a premium regional healthcare provider focused on advanced medical treatment, preventive healthcare, aging-related services, and medical tourism. The company’s growth strategy has emphasized expanding specialized treatment capacity, increasing operational efficiency across its hospital network, and enhancing digital healthcare capabilities. BDMS has invested in precision medicine, telemedicine infrastructure, preventive health programs, and wellness-related initiatives intended to support long-term demographic trends in Thailand and broader Asia.

Historically, BDMS expanded through acquisitions and consolidation of major Thai hospital groups, including the integration of Samitivej, Phyathai, and Paolo hospitals into its broader network. The company has also invested in healthcare technology systems, research collaborations, and high-acuity medical facilities to strengthen its competitive position against regional healthcare providers in Singapore and other ASEAN markets. BDMS continues to focus on complex care services and international patient intake as strategic drivers of long-term growth.

Geographic Footprint

BDMS is headquartered in Bangkok, Thailand, and operates an extensive network of hospitals and healthcare facilities throughout the country. Its facilities are located across major urban centers and regional provinces, including strong concentrations in Bangkok, Chiang Mai, Phuket, Pattaya, and other economically significant areas. The company maintains one of the broadest private healthcare footprints in Thailand, allowing it to serve both local populations and international visitors.

Although its physical operations are primarily domestic, BDMS has substantial international exposure through medical tourism and cross-border healthcare demand. The company serves patients from the Middle East, China, Myanmar, Cambodia, Laos, and other parts of Asia-Pacific. BDMS has established international marketing offices and referral relationships designed to attract overseas patients seeking specialized treatment and premium healthcare services in Thailand.

Leadership & Governance

BDMS was founded and developed under the leadership of Dr. Prasert Prasarttong-Osoth, who played a central role in building the company into Thailand’s leading private healthcare network through hospital expansion and strategic acquisitions. The company’s leadership philosophy has emphasized long-term healthcare infrastructure development, clinical quality standards, physician specialization, and international competitiveness in medical services.

Key executives and leadership figures have included:

  • Dr. Prasert Prasarttong-Osoth – Founder and Chairman
  • Dr. Poramaporn Prasarttong-Osoth – President and Executive leadership role
  • Nathorn Chaiyawat – Senior Executive leadership role associated with finance and operations
  • Dr. Chatree Duangnet – Executive leadership associated with hospital operations and medical services

Certain executive titles and reporting structures may vary across annual reporting periods. Publicly available information regarding some leadership positions is not fully consistent across all sources; therefore, data on specific executive responsibilities may be inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $224.41
B
AAPL NASDAQ $324.96
B
AVGO NASDAQ $367.24
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $106.09
Top Financial Stocks
See All »
B
B
JPM NYSE $356.22
B
V NYSE $378.40
Top Health Care Stocks
See All »
B
LLY NYSE $1,160.08
B
JNJ NYSE $275.21
B
ABBV NYSE $261.72
Top Real Estate Stocks
See All »
B
PLD NYSE $136.59
B
EQIX NASDAQ $1,019.24